191 related articles for article (PubMed ID: 12539171)
1. Lymphangiogenesis in tumors: what do we know?
Reis-Filho JS; Schmitt FC
Microsc Res Tech; 2003 Feb; 60(2):171-80. PubMed ID: 12539171
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
5. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of markers and growth factors for lymphatic endothelium].
Waś H
Postepy Biochem; 2005; 51(2):209-14. PubMed ID: 16209358
[TBL] [Abstract][Full Text] [Related]
8. Markers for microscopic imaging of lymphangiogenesis and angiogenesis.
Baluk P; McDonald DM
Ann N Y Acad Sci; 2008; 1131():1-12. PubMed ID: 18519955
[TBL] [Abstract][Full Text] [Related]
9. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
10. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenesis in malignant tumours: Does it occur?
Clarijs R; Ruiter DJ; de Waal RM
J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
[TBL] [Abstract][Full Text] [Related]
12. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.
Schledzewski K; Falkowski M; Moldenhauer G; Metharom P; Kzhyshkowska J; Ganss R; Demory A; Falkowska-Hansen B; Kurzen H; Ugurel S; Geginat G; Arnold B; Goerdt S
J Pathol; 2006 May; 209(1):67-77. PubMed ID: 16482496
[TBL] [Abstract][Full Text] [Related]
15. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
16. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients.
Geissler HJ; Dashkevich A; Fischer UM; Fries JW; Kuhn-Régnier F; Addicks K; Mehlhorn U; Bloch W
Eur J Cardiothorac Surg; 2006 May; 29(5):767-71. PubMed ID: 16439147
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic endothelium: a new frontier of metastasis research.
Karkkainen MJ; Mäkinen T; Alitalo K
Nat Cell Biol; 2002 Jan; 4(1):E2-5. PubMed ID: 11780131
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.
Kato S; Shimoda H; Ji RC; Miura M
Anat Sci Int; 2006 Jun; 81(2):71-83. PubMed ID: 16800291
[TBL] [Abstract][Full Text] [Related]
20. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]